Shandong Xinhua Pharmaceutical Co Ltd (000756) — Cash Flow-to-Debt Ratio
Shandong Xinhua Pharmaceutical Co Ltd (000756) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2023, meaning its operating cash flow of CN¥56.11 Million could theoretically repay 0% of its total liabilities (CN¥3.22 Billion) in one year. Explore long-term investment intensity of Shandong Xinhua Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Xinhua Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Shandong Xinhua Pharmaceutical Co Ltd across 10 annual periods. Also explore balance sheet size of Shandong Xinhua Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
Year-by-year debt coverage analysis for Shandong Xinhua Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Shandong Xinhua Pharmaceutical Co Ltd (000756) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥367.61 Million | CN¥3.80 Billion | ▲ +27.9% |
| 2023 | 0.08x | CN¥265.28 Million | CN¥3.51 Billion | ▼ -61.0% |
| 2022 | 0.19x | CN¥758.24 Million | CN¥3.92 Billion | ▲ +175.1% |
| 2021 | 0.07x | CN¥259.12 Million | CN¥3.68 Billion | ▼ -38.0% |
| 2020 | 0.11x | CN¥420.19 Million | CN¥3.70 Billion | ▲ +8.4% |
| 2019 | 0.10x | CN¥348.27 Million | CN¥3.33 Billion | ▲ +0.9% |
| 2018 | 0.10x | CN¥323.91 Million | CN¥3.12 Billion | ▼ -28.3% |
| 2017 | 0.14x | CN¥389.97 Million | CN¥2.69 Billion | ▼ -12.9% |
| 2016 | 0.17x | CN¥439.35 Million | CN¥2.64 Billion | ▲ +19.6% |
| 2015 | 0.14x | CN¥348.64 Million | CN¥2.51 Billion | — |